Lexicon Pharmaceuticals, Inc.

LXRXNASDAQ • USD
1.77 USD
↘ 0.03 (1.40%)🟢PRE MARKET (AS OF 04:04 AM EST)
🟢Market: OPEN

Lexicon Pharmaceuticals, Inc. (LXRX) trades at $1.77 per share. Technicals currently rate "Neutral" while our fundamental analysis reads "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Nov 13, 2026.

Open?$1.75
High?$1.77
Low?$1.75
Prev. Close?$1.79
Volume?51
Avg. Volume?2.1M
VWAP?$1.77
Rel. Volume?0.00x
Bid / Ask
Bid?$1.44 × 100
Ask?$2.03 × 100
Spread?$0.59
Midpoint?$1.73
Valuation & Ratios
Market Cap?797.0M
Shares Out?445.2M
Float?226.4M
Float %?50.9%
P/E Ratio?N/A
P/B Ratio?4.86
EPS?-$0.14
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
Employees
81
Market Cap
797.0M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2000-04-07
Address
2445 TECHNOLOGY FOREST BLVD.
THE WOODLANDS, TX 77381
Phone: (281) 863-3000
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
0
Momentum?
50
Short Sent.?
28
Piotroski F-Score?3/9Weak
Altman Z-Score?-5.62Distress
Confidence?63%Moderate
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?11.43%High
Short Interest?25.9M
Days to Cover?14.0
Free Float226.4M
Avg Daily Volume1.8M
Settlement Date2026-10-30
Financial Health
Current Ratio?10.63Strong
Quick Ratio?10.56Strong
Cash Ratio?2.48Strong
Debt/Equity?0.32Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A▾
P/B?
Peers
100
S&P
38
4.86FAIR▾
P/S?
Peers
100
S&P
3
20.76HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-13.8CHEAP▾
EV/Sales?
Peers
100
S&P
3
20.97HIGH▾
Returns & Efficiency
ROE?
S&P
3
-38.1%WEAK▾
ROA?
S&P
3
-25.8%WEAK▾
Cash Flow & Enterprise
FCF?$-49234000
Enterprise Value?$804.8M
Fundamentals ratios updated end of day